Innovation

Bounteous Acquires Cartesian To Strengthen Data And Analytics Capabilities

By Amit Chowdhry ● May 14, 2026

Bounteous announced the acquisition of Cartesian to accelerate enterprise AI adoption by strengthening its data, analytics, and telecommunications expertise.

Iterative Health: Cardiology Site Acquisition Expands Texas Clinical Research Network

By Amit Chowdhry ● May 14, 2026

Iterative Health announced the acquisition of three cardiology research sites from NextStage Clinical Research, expanding the company’s cardiovascular clinical trial capabilities across Texas.

YouTube: New Creator Shows From Trevor Noah, Dude Perfect, Alex Cooper, Quen Blackwell, And More

By Amit Chowdhry ● May 14, 2026

YouTube unveiled a major slate of new and returning Creator Shows at Brandcast 2026, featuring high-profile creators, athletes, comedians, and entertainers, including Trevor Noah, Alex Cooper, Quen Blackwell, Dwyane Wade, and Dude Perfect.

Ford Launches U.S.-Assembled Battery Energy Storage Business

By Amit Chowdhry ● May 14, 2026

Ford Motor Company formally introduced Ford Energy, a wholly owned subsidiary focused on providing United States-assembled battery energy storage systems (BESS) for utilities, data centers, and large industrial and commercial customers across the United States.

MS&AD Insurance Group Holdings Acquires 18% Stake In Barings

By Amit Chowdhry ● May 14, 2026

MassMutual and its global alternative asset management subsidiary, Barings, announced that MS&AD Insurance Group Holdings has completed the acquisition of an 18% equity stake in Barings through its subsidiary, Mitsui Sumitomo Insurance Co., Ltd. (MSI), a major Japanese insurance company.

Iridium: $366.7 Million Aireon Acquisition Advances Aviation Safety Strategy

By Amit Chowdhry ● May 14, 2026

Iridium Communications announced it has entered into a definitive agreement to acquire Aireon, operator of the world’s only space-based Automatic Dependent Surveillance-Broadcast (ADS-B) air traffic surveillance system. The transaction is designed to strengthen Iridium’s position in aviation safety by combining space-based surveillance, satellite communications, positioning, navigation, and timing (PNT) services, and aviation operational data on a single global network.

GridCARE: $64 Million Series A Raised To Create New ‘Power Acceleration’ Category For AI

By Amit Chowdhry ● May 14, 2026

GridCARE announced it has raised a $64 million oversubscribed Series A round to accelerate what the company describes as a new category called “Power Acceleration” for AI infrastructure. The financing was led by Sutter Hill Ventures, with participation from John Doerr, along with utility and institutional investors including National Grid Partners, Future Energy Ventures, Emerson Collective, Stanford University, and existing investors including Xora, Aina Ventures, Overture, Acclimate Ventures, and Clearvision Ventures.

Amberd.ai Partners With RL Jones To Streamline Tariff Refunds And Cross-Border Logistics Operations Using AI

By Amit Chowdhry ● May 14, 2026

Amberd.ai announced a partnership with R.L. Jones Customhouse Brokers to deploy an AI decision platform designed to streamline tariff refund management and cross-border logistics operations tied to IEEPA tariff processes.

Ascentage Pharma: Interview With Co-Founder & CEO Dr. Dajun Yang About The Global Hematology-Oncology Company

By Amit Chowdhry ● May 14, 2026

Ascentage Pharma is a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development, and commercialization of novel, differentiated therapies to address unmet medical needs in cancer. With two approved products in China, Olverembatinib for chronic myeloid leukemia (CML) and Lisaftoclax for chronic lymphocytic leukemia (CLL), and a growing portfolio of global clinical trials, including registrational studies cleared by the FDA and the European Medicines Agency, Ascentage Pharma is advancing treatments across hematologic malignancies including CML, CLL, acute lymphoblastic leukemia (ALL), high- and intermediate-risk myelodysplastic syndrome (MDS), and is also expanding its pipeline in solid tumors. Pulse 2.0 interviewed Co-Founder, Chairman, and Chief Executive Officer Dr. Dajun Yang to learn more about the company.